| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.51 | 0.0002 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0002 |